Luckwel Pharmaceuticals Inc. Patent Applications Pending
2 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-06-18: Application 63212439; Invention INJECTABLE FORMULATION OF HYDROXYCHLOROQUINE; Applicant Luckwel Pharmaceuticals Inc.; Status Provisional Application Expired.
- 2021-04-28: Application 63181062; Invention MINI-TABLETS IN CAPSULE DOSAGE FORM COMPRISING ATORVASTATIN; Applicant Luckwel Pharmaceuticals Inc.; Status Provisional Application Expired.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2021-06-18 | 63212439 | INJECTABLE FORMULATION OF HYDROXYCHLOROQUINE | Luckwel Pharmaceuticals Inc. | Provisional Application Expired | Kingrich Lee | United States | ||
| 2021-04-28 | 63181062 | MINI-TABLETS IN CAPSULE DOSAGE FORM COMPRISING ATORVASTATIN | Luckwel Pharmaceuticals Inc. | Provisional Application Expired | Kingrich Lee | United States |